1. Home
  2. LCID vs BLTE Comparison

LCID vs BLTE Comparison

Compare LCID & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$11.20

Market Cap

3.7B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$169.05

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
BLTE
Founded
2007
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.1B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
LCID
BLTE
Price
$11.20
$169.05
Analyst Decision
Hold
Strong Buy
Analyst Count
8
8
Target Price
$24.00
$161.57
AVG Volume (30 Days)
8.6M
237.7K
Earning Date
02-24-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,065,533,000.00
N/A
Revenue This Year
$64.76
N/A
Revenue Next Year
$84.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$9.50
$49.00
52 Week High
$35.90
$174.78

Technical Indicators

Market Signals
Indicator
LCID
BLTE
Relative Strength Index (RSI) 49.07 64.28
Support Level $10.55 $156.52
Resistance Level $11.69 $171.63
Average True Range (ATR) 0.64 8.88
MACD 0.14 0.26
Stochastic Oscillator 65.28 79.00

Price Performance

Historical Comparison
LCID
BLTE

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations and through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

Share on Social Networks: